TrialAnnals of medicine2021

A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra

Hong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.